Patients who underwent transcatheter aortic valve implantation (TAVI) at experienced medical centers had significant improvement in valve function as well as low mortality and stroke rates at 30...
A late-breaking stem cell trial presented at the American College of Cardiology (ACC)Annual Scientific Session showed only minor improvement in heart pumping...
The American College of Cardiology (ACC) 2012 Scientific Session, held March 24-27 in Chicago, was the first major cardiology show this year for vendors to display their latest innovations. A...
Transcatheter heart valves are viewed as the poster children devices representing the latest in cutting-edge cardiac therapy technology. For this reason, it is not surprising nearly all the...
Based on my observations and those of the doctors on the Diagnostic & Interventional Cardiology Editorial Advisory Board, we created the following list of predictions of what will be hot...
With the approval of the Sapien valve in November 2011, transcatheter aortic valve implantation (TAVI) technology is expected to revolutionize heart valve replacement with a minimally invasive...
Recently, the U.S. Food and Drug Administration (FDA) has approved the Edwards Sapien transcatheter heart valve for patients with aortic stenosis (AS), who are not suitable for standard aortic...
Within the United States, the anticipated approval and launch of TAVR has received considerable attention, with speculation about who will perform the procedure. For example, many physicians...
Each year I attend Transcatheter Cardiovascular Therapeutics (TCT), I comb the event and its sessions looking for the next big trend or technological innovations in cardiovascular devices. Below...
The U.S. Food and Drug Administration (FDA) today approved the first transcatheter aortic heart valve in the United States - the Sapien THV. Experts say the approval will open a new chapter in how...
